Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The nose-to-brain pathway has been proven to be a shortcut for direct drug delivery to the brain. However, whether and to what extent nanoparticles can be delivered through this passage is still awaiting validation with evidence. In this study, nose-to-brain transportation of nanoparticles is tracked via fluorescence bioimaging strategies using nanoemulsions (NEs) as model carriers. Identification of NEs in biological tissues is based on the on → off signal switching of a new type of environment-responsive embedded dyes, P2 and P4, and two conventional probes, DiR and coumarin-6 (C6), are embedded to represent the cargoes. Evidence for the translocation of NEs was collected either via live imaging or ex vivo histological examination in rats after nasal administration. Results suggest that NEs with a particle size of about 100 nm, either naked or coated with chitosan, have longer retention duration in nostrils and slower mucociliary clearance than larger ones. P2 signals, representing integral NEs, can be found in mucosa and trigeminal nerves for all size groups, whereas only weak P2 signals are detected in the olfactory bulb for chitosan-coated NEs of 100 nm. Confocal microscopy further confirms the translocation of integral 100 nm NEs in nasal mucosa and along the trigeminal nerve in decremental intensity. Weak signals of the P4 probe, also representing integral NEs, can be detected in the olfactory bulb but few in the brain. NEs as large as 900 nm cannot be transported to the olfactory bulb. However, the DiR or C6 signals that represent the cargoes can be found in significant amounts along the nose-to-brain pathway and finally reach the brain. Evidence shows that integral NEs can be delivered to the olfactory bulb, but few to the brain, whereas the cargoes can be released and permeated into the brain in greater amounts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NEs of about 100 nm have a prolonged residence duration in the nasal cavity, whereas NEs of larger sizes are characterized by faster clearance.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [72]
In the citing paper
“Particle size, rather than surface coating with chitosan or thickening with thermosensitive in situ gel, plays the most important role in determining the in vivo fate of NEs.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [72]
In the citing paper
“Imaging showed that NEs of 100 nm were transported through the trigeminal and the olfactory nerves to the olfactory bulb.”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [72]
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides
Drin, G., Cottin, S., Blanc, E., Rees, A. R., & Temsamani, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303938200 · Cited by 530
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Chitosan in nasal delivery systems for therapeutic drugs
Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 444
Zhuang, X., Teng, Y., Samykutty, A., Mu, J., Deng, Z., Zhang, L., Cao, P., Rong, Y., Yan, J., Miller, D., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.188 · Cited by 294
Yang, Z.-Z., Zhang, Y.-Q., Wang, Z.-Z., Wu, K., Lou, J.-N., & Qi, X.-R. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.009 · Cited by 248
Kanazawa, T., Akiyama, F., Kakizaki, S., Takashima, Y., & Seta, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.036 · Cited by 241
Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting
Mahajan, H. S., Mahajan, M. S., Nerkar, P. P., & Agrawal, A. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838014 · Cited by 212
Gartziandia, O., Herran, E., Pedraz, J. L., Carro, E., Igartua, M., & Hernandez, R. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.06.054 · Cited by 194
Johnson, N. J., Hanson, L. R., & Frey, W. H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100029t · Cited by 194
Bhavna, Md, S., Ali, M., Ali, R., Bhatnagar, A., Baboota, S., & Ali, J. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.03.022 · Cited by 181
Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting
Kumar, M., Misra, A., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802476504 · Cited by 179
Mistry, A., Stolnik, S., & Illum, L. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00088 · Cited by 179
Kanazawa, T., Taki, H., Tanaka, K., Takashima, Y., & Okada, H. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0440-7 · Cited by 166
Strategies To Deliver Peptide Drugs to the Brain
Lalatsa, A., Schatzlein, A. G., & Uchegbu, I. F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400680d · Cited by 160
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption
Smith, J. M., Dornish, M., & Wood, E. J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.020 · Cited by 138
Physicochemical and physiological considerations for efficient nose-to-brain targeting
Bahadur, S., & Pathak, K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.636801 · Cited by 137
Hu, X., Zhang, J., Yu, Z., Xie, Y., He, H., Qi, J., Dong, X., Lü, Y., Zhao, W., & Wu, W. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.06.013 · Cited by 131
Self-citationMistry, A., Glud, S. Z., Kjems, J., Randel, J., Howard, K. A., Stolnik, S., & Illum, L. (2009) · Journal of Drug Targeting · doi:10.1080/10611860903055470 · Cited by 130
Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery
Hu, X., Fan, W., Yu, Z., Lü, Y., Qi, J., Zhang, J., Dong, X., Zhao, W., & Wu, W. (2015) · Nanoscale · doi:10.1039/c5nr07474f · Cited by 120
Self-citationIntranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting
Vyas, T. K., Babbar, A. K., Sharma, R. K., & Misra, A. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500246217 · Cited by 113
Levels of dopamine in blood and brain following nasal administration to rats
Dahlin, M., Jansson, B., & Björk, E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00151-8 · Cited by 97
Joshi, A. S., Patel, H. S., Belgamwar, V. S., Agrawal, A., & Tekade, A. R. (2012) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-012-4702-7 · Cited by 97
Shinde, R. L., Bharkad, G. P., & Devarajan, P. V. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.08.008 · Cited by 78
Intranasal delivery of therapeutic proteins for neurological diseases
Malerba, F., Paoletti, F., Capsoni, S., & Cattaneo, A. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.588204 · Cited by 73
Absorption, Disposition and Pharmacokinetics of Nanoemulsions
Lu, Y., Qi, J., & Wu, W. (2012) · Current Drug Metabolism · doi:10.2174/138920012800166544 · Cited by 64
Self-citationXie, Y., Hu, X., He, H., Xia, F., Ma, Y., Qi, J., Dong, X., Zhao, W., Lü, Y., & Wu, W. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02706c · Cited by 62
Self-citationDISTRIBUTION OF ANTIHISTAMINES INTO THE CSF FOLLOWING INTRANASAL DELIVERY
CHOU, K.-J., & DONOVAN*, M. D. (1997) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199705)18:4<335::aid-bdd22>3.0.co;2-w · Cited by 58
Xie, Y., Jiang, S., Xia, F., Hu, X., He, H., Yin, Z., Qi, J., Lü, Y., & Wu, W. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00237d · Cited by 53
Self-citationPatel, R. B., Patel, M. R., Bhatt, K. K., Patel, B. G., & Gaikwad, R. V. (2014) · Drug Delivery · doi:10.3109/10717544.2014.908980 · Cited by 50
Mustafa, G., Alrohaimi, A. H., Bhatnagar, A., Baboota, S., Ali, J., & Ahuja, A. (2014) · Drug Delivery · doi:10.3109/10717544.2014.923064 · Cited by 26
Microemulsion based intranasal delivery system for treatment of insomnia
Porecha, S. K., Shah, T. R., Jogani, V. V., Naik, S., & Misra, A. R. (2009) · Drug Delivery · doi:10.1080/10717540802560381 · Cited by 25
Liposomes interiorly thickened with thermosensitive nanogels as novel drug delivery systems
Zhang, B., Chen, J., Lü, Y., Qi, J., & Wu, W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.020 · Cited by 22
Self-citation
Research works printed but not linked: 1
- Huang, 1996, Int. J. Pharm. Adv., 1, 298
Cited by
Chitosan-Based Nanomaterials for Drug Delivery
Li, J., Cai, C., Li, J., Li, J., Li, J., Sun, T., Wang, L., Wu, H., & Yu, G. (2018) · Molecules · doi:10.3390/molecules23102661 · Cited by 481
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Drug delivery to the central nervous system
Nance, E., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 414
Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Bourganis, V., Kammona, O., Alexopoulos, A., & Kiparissides, C. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.009 · Cited by 357
“, fluorescent dye) and it is the nanoemulsion droplet diameter that mainly contributes to the nanoemulsion fate post intranasal administration in comparison with the mucoadhesive coating or the gel impregnation [14].”
BackgroundSurface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
“Ahmad [75] studied the permanence of a nanoemulsion made with Labrafac®WL1349/Labrafac®CC (Gattefossé, Saint-Priest, France) and Solutol®HS15 (BASF, Mumbai, India) in the nasal cavity of rats from 0.”
Method
Metadata
- Authors
- Ahmad, E., Feng, Y., Qi, J., Fan, W., Ma, Y., He, H., Xia, F., Dong, X., Zhao, W., Lu, Y., & Wu, W.
- Affiliations
- Fudan University (CN)
- Dahua Hospital (CN)
- Henan University (CN)
- Corresponding author
- Wu, Wei
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 9
- Issue
- 3
- Pages
- 1174-1183
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W2566085093
- Cited by
- 194
- References
- 36
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 23 · 2023: 25 · 2022: 27 · 2021: 23 · 2020: 27 · 2019: 17 · 2018: 16 · 2017: 4
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nanoscale (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (21372063, 81573363)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- nose-to-brain delivery, nanoemulsions, intranasal drug delivery, olfactory bulb, trigeminal nerve, chitosan-coated nanoparticles, particle size effects, mucociliary clearance, fluorescent probes, DiR, coumarin 6, nanoparticle translocation, brain penetration
- MeSH terms
- Administration, Intranasal, Animals, Brain, Nasal Mucosa, Drug Delivery Systems, Rats, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.